Form 4: Ionis Pharmaceuticals EVP Acquires Shares Under Employee Stock Purchase Plan

Patrick R. O'Neil, EVP, CLO & General Counsel of Ionis Pharmaceuticals, acquired 554 shares of common stock through the company's employee stock purchase plan on February 28, 2025.

Summary

• On February 28, 2025, Patrick R. O'Neil, the EVP, CLO & General Counsel of Ionis Pharmaceuticals, acquired 554 shares of the company's common stock.
• The shares were purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan.
• The purchase price was $28.2115 per share.
• Following the transaction, O'Neil directly owns 56,799 shares of Ionis Pharmaceuticals common stock.
• The acquired shares cannot be sold until August 28, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction indicating executive participation in the company's stock purchase plan, suggesting confidence in the company's prospects.

Positives

• The purchase demonstrates confidence in the company's future prospects from a high-ranking executive.

Future Outlook

There is no future outlook provided in the document.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in the pharmaceutical industry. It provides transparency regarding insider transactions and aligns with regulatory requirements.

Comparison to Industry Standards

• Employee stock purchase plans are a common form of compensation in the pharmaceutical industry, used by companies like Amgen, Gilead Sciences, and Biogen to incentivize employees and align their interests with shareholders.
• The terms of Ionis Pharmaceuticals' plan, including the holding period until August 28, 2025, are typical of such plans, designed to encourage long-term investment in the company.
• Executive stock ownership is also a common metric tracked by investors to gauge management's confidence in the company's prospects, with levels varying based on company size and executive role.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company executive.
• Employees participating in the stock purchase plan benefit from the opportunity to acquire company stock at a potentially discounted price.

Key Dates